Alexandra M Levine - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alexandra M Levine

Showing results (101-110 of 119) with videos related to

Pageof 12

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemiasFrancis J Giles, Stefan Faderl, Deborah A Thomas, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047Alexandra M Levine, Ariela Noy, Jeannette Y Lee, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004

Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical responseWilliam Larry Gluck, Deborah Hurst, Alan Yuen, et al.

Viral Immunology|February 6, 2014

The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected womenHoward D Strickler, Jeffrey Martinson, Seema Desai, et al.

JAMA|July 24, 2012

Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infectionMarla J Keller, Robert D Burk, Xianhong Xie, et al.

Drug and Alcohol Dependence|February 13, 2007

Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenJudith A Cook, Dennis D Grey, Jane K Burke-Miller, et al.

Journal of the National Cancer Institute|April 21, 2005

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive womenHoward D Strickler, Robert D Burk, Melissa Fazzari, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010

Marginal and mixed-effects models in the analysis of human papillomavirus natural history dataXiaonan Xue, Stephen J Gange, Ye Zhong, et al.

Journal of Lower Genital Tract Disease|April 7, 2007

Outcomes after treatment of cervical intraepithelial neoplasia among women with HIVL Stewart Massad, Melissa J Fazzari, Kathryn Anastos, et al.

AIDS (London, England)|June 27, 2008

Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive womenJudith A Cook, Jane K Burke-Miller, Mardge H Cohen, et al.

Pageof 12

Search research articles

Showing results (101-110 of 119) with videos related to

Sort By:

Pageof 12

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemiasFrancis J Giles, Stefan Faderl, Deborah A Thomas, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004

Viral Immunology|February 6, 2014

JAMA|July 24, 2012

Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infectionMarla J Keller, Robert D Burk, Xianhong Xie, et al.

Drug and Alcohol Dependence|February 13, 2007

Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenJudith A Cook, Dennis D Grey, Jane K Burke-Miller, et al.

Journal of the National Cancer Institute|April 21, 2005

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive womenHoward D Strickler, Robert D Burk, Melissa Fazzari, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010

Marginal and mixed-effects models in the analysis of human papillomavirus natural history dataXiaonan Xue, Stephen J Gange, Ye Zhong, et al.

Journal of Lower Genital Tract Disease|April 7, 2007

Outcomes after treatment of cervical intraepithelial neoplasia among women with HIVL Stewart Massad, Melissa J Fazzari, Kathryn Anastos, et al.

AIDS (London, England)|June 27, 2008

Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive womenJudith A Cook, Jane K Burke-Miller, Mardge H Cohen, et al.

Pageof 12